The combined analysis of ADAM15 and CEA increased the diagnostic sensitivity up to 67% and was higher than the assessment of classical tumor markers in combination (CEA + CA19-9 = 62%) (Table 6 and Figure 1). The gene discussed is CEACAM5; the disease is neoplasm.